Biologic Formulation Design & Optimization
Design stable biologic formulations with ICH-compliant excipient selection and stability protocols
What You Can Do
You can design optimized formulations for biologic drugs by analyzing physicochemical properties, selecting and calculating excipient concentrations, choosing appropriate drug product formats (liquid, lyophilized, sustained-release), and planning comprehensive stability protocols. The skill guides you through data-driven decision-making to extend shelf-life, prevent aggregation and oxidation, ensure manufacturability, and prepare CMC documentation for regulatory submission.
Features
evaluate pH sensitivity, ionic strength effects, freeze-thaw stability, surface denaturation risk, and oxidation mechanisms specific to your biologic
identify compatible stabilizers, buffers, antioxidants, surfactants, and cryoprotectants with scientific rationale for each choice
calculate optimal excipient levels based on API type (mAb, protein, peptide) and formulation science best practices
compare liquid, lyophilized powder, and sustained-release strategies with pros/cons for your therapeutic indication
structure real-time, accelerated, and photostability studies with defined time points and acceptance criteria
generate formulation composition, manufacturing process, and stability testing summaries for submission-ready quality reports
plan forced degradation studies to identify potential impurities and establish stability-indicating method requirements
model degradation kinetics to project product stability and establish expiry dating
Example Output
Example 1: Monoclonal Antibody Formulation
- API Analysis: mAb at 50 mg/mL; sensitive to freeze-thaw, low pH aggregation, oxidation at His residues
- Proposed Formulation: 50 mM sodium phosphate pH 7.0, 150 mM NaCl, 0.01% polysorbate 80, 5% sucrose, 5 mM methionine
- Rationale: Buffer maintains pH stability; sucrose prevents freeze-thaw damage; polysorbate 80 reduces surface adsorption; methionine quenches reactive oxygen species
- Stability Plan: 2–8°C, 25°C/60% RH, 40°C/75% RH; 6, 12, 24 month timepoints
Example 2: Recombinant Protein Optimization
- Current Issue: 4-month shelf-life; visible aggregates by month 6
- Root Cause Analysis: Elevated temperature, low antioxidant coverage
- Revised Formulation: Add 2 mM EDTA (chelate metal ions), increase sodium ascorbate to 1 mM, reduce storage temperature to 2–8°C
- Expected Outcome: 24-month shelf-life at reduced aggregation rate
Example 3: Therapeutic Peptide Lyophilized Cake
- Format Decision: Liquid formulation showed hydrolysis; lyophilization selected
- Excipient Cake Composition: 2% trehalose, 2% mannitol (cryoprotectants), 10 mM histidine buffer pH 6.5, 0.5% human serum albumin (stabilizer)
- Validation: Moisture <2%, cake appearance, reconstitution time <2 min, potency recovery >95%
What's Included
- SKILL.md instruction file with formulation design framework:
- API Characterization Template: physicochemical property assessment checklist
- Excipient Selection Matrix: compatibility reference for mAbs, proteins, peptides with rationale documentation
- Formulation Composition Calculator: excipient concentration optimization based on API type and route
- ICH Stability Protocol Template: real-time, accelerated, and photostability study designs with acceptance criteria
- CMC Documentation Outline: regulatory-ready formulation composition, manufacturing, and testing summaries
Who It's For
- Formulation Scientists — designing initial and optimized biologic drug formulations with regulatory compliance
- Bioprocess Engineers — selecting excipients and formats that balance stability with manufacturability
- Quality by Design (QbD) Teams — developing science-based formulation strategies and stability protocols
- CMC Writers — preparing Chemistry, Manufacturing, and Controls documentation for regulatory submissions
- R&D Project Managers — evaluating formulation feasibility and shelf-life projections early in development
Best For
- Early-stage formulation development for monoclonal antibodies, recombinant proteins, and therapeutic peptides
- Troubleshooting instability issues (aggregation, precipitation, oxidation, hydrolysis)
- Selecting optimal drug product format (liquid, lyophilized powder, sustained-release)
- Designing ICH-compliant stability studies with defined time points and acceptance criteria
- Generating regulatory CMC documentation for IND/BLA submissions
You might also like
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
This skill generates comprehensive fault study reports, protection coordination analyses, and compliance documentation for electrical power systems. It systematically documents fault scenarios, relay settings, coordination curves, and technical specifications required for grid operations and regulatory compliance. You produce production-ready documentation that meets industry standards—IEEE, NERC, and regional RTO requirements.
by kody-wThis skill interprets your FEA simulation results and extracts actionable design improvements. You can pinpoint stress concentrations, validate designs against safety factors and material limits, and receive specific geometry recommendations to reduce weight or improve performance. By automating FEA post-processing, you compress design iteration cycles and make engineering decisions faster.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w
Analyze your PLC code and ladder logic to identify logic errors, safety violations, and inefficiencies before they reach production. You'll get detailed diagnostics of control system failures, safety compliance verification against IEC 61131 standards, and optimization recommendations for automation sequences. This skill helps you prevent costly downtime, ensure worker safety, and improve system performance across manufacturing operations.
by kody-w
You can translate raw variant catalogs and NGS data into actionable target hypotheses by synthesizing variant effect predictions, population frequency metrics, disease association evidence, and protein interaction networks. This skill automates the connection between molecular findings and clinical relevance, producing comprehensive variant assessments that justify target selection across pharmaceutical development stages and support regulatory submissions.
by kody-w
Create comprehensive tool specifications tailored to your manufacturing process, material combinations, and performance requirements. Analyze cutting speeds, feeds, tool life, and thermal behavior to predict tool performance and identify optimization opportunities. You can compare design alternatives, predict failure modes, and generate compliance documentation for production tooling decisions.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w